Events

Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve(casirivimab and imdevimab), for the treatment of patients with mild to moderate…
Read More...

Tango Therapeutics which is a biotechnology company creating novel, targeted medicines for specific cancer subtypes claimed the addition of three experienced leaders with deep…
Read More...

Roche declared that its new hematology testing solution, the cobas m 511 integrated hematology analyzer has received 510(k) clearance from the U.S Food and Drug Administration. The…
Read More...

Sweetch which is a mobile-health app that helps prevent and enhance outcomes in diabetes by encouraging long-term behavioral change declared thee outcomes of its clinical trial…
Read More...

CE Mark approval was sought for EPD's Cardiac Mapping and Navigation System. The system helps electrophysiologists navigate the heart by generating a succinct 3D Map while imaging and…
Read More...

Atrium Health's Levine Children's Hospital proved to be a new trial site to test a new medicine for children that can regulate and stabilize their blood pressure in fatal circumstances.…
Read More...

Genomics England and Lantern Pharma that emphasizes on precision oncology incorporating Artificial intelligence asserted that Lantern will associate with Genomics England's Discovery…
Read More...

Rubius Therapeutics asserted the appointment of Spencer Fisk as Senior Vice-President, Manufacturing. Rubius Therapeutics is a biotechnology company endeavoring the creation of a new…
Read More...

GT Biopharma focused on the development and commercialization of novel cancer immunotherapy products as well as central nervous system treatments asserted the appointment of Shawn M.…
Read More...

Arterys Inc declared its fifth 510 (k) clearance for Arterys Oncology AI suite and is milestone indicative of the company's momentum in applying AI to further medical imaging accuracy…
Read More...

Bristol-Myers Squibb Company and Nektar Therapeutics collaborate commercially for Nektar's lead immuno-oncology program, NKTR-214. The companies will jointly develop and…
Read More...

U.S Food and Drug Administration paved way for the marketing of the Viz.AI Contact application which is a type of clinical decision support software designed to interpret computed…
Read More...